Send the following on WhatsApp
Continue to ChatUpdate: French Biotech Closes €27M IPO to be the First to Treat Rare Disease in Children on Labiotech.eu https://www.labiotech.eu/trends-news/advicenne-ipo-rare-disease-children/
Update: French Biotech Closes €27M IPO to be the First to Treat Rare Disease in Children on Labiotech.eu https://www.labiotech.eu/trends-news/advicenne-ipo-rare-disease-children/